ArticleStem cells translational medicine2023

Management of Retinitis Pigmentosa Via Wharton's Jelly-Derived Mesenchymal Stem Cells or Combination With Magnovision: 3-Year Prospective Results.

Emin Ozmert et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.